Vesugen (20mg) is a synthetic short-chain peptide supplied exclusively as a laboratory research material. It may be used in controlled in vitro studies, analytical testing, peptide characterization, and other non-clinical research workflows involving short regulatory peptide sequences.
Each vial contains 20mg of lyophilized Vesugen. Lot-specific analytical documentation is available through the Nordsci Certificate of Analysis library. Researchers should consult the applicable COA for reported identity, purity, test methods, and other batch-specific findings.
Vesugen is not a drug, dietary supplement, food, cosmetic, or veterinary product. It has not been evaluated or approved for clinical, diagnostic, therapeutic, or preventive applications.
Research Classification: Laboratory research material
Form: Lyophilized peptide powder
Quantity: 20mg per vial
Testing Documentation: Lot-specific Certificate of Analysis available
Permitted Use: Controlled laboratory and analytical research only
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
Vesugen is a synthetic short-chain peptide supplied in lyophilized form exclusively for controlled laboratory research. It may be examined through analytical characterization, peptide-interaction studies, assay development, and other non-clinical research workflows involving defined peptide sequences.
Short-chain peptides are frequently evaluated as molecular research materials because their compact structures can be incorporated into controlled experiments involving peptide stability, analytical behavior, molecular interactions, and sequence-dependent activity. Findings obtained with Vesugen should be interpreted within the limitations of the selected model, methodology, and experimental conditions.
Vesugen (20mg) – Research Specifications:
| Compound | Vesugen |
| Quantity | 20mg per vial |
| Compound Type | Synthetic short-chain peptide research material |
| Purity / Identity | Refer to the lot-specific Certificate of Analysis for reported analytical findings |
| Appearance | Lyophilized peptide powder |
| Storage Conditions | Store sealed in a cool, dry environment protected from heat, light, and moisture; consult the applicable COA |
| Research Use Only | For laboratory research use only. Not for human or animal consumption. |
Vesugen is a synthetic peptide material used in controlled laboratory settings. Research involving this compound may examine its physicochemical characteristics, sequence-dependent behavior, stability, analytical profile, or interactions within defined experimental systems.
Short regulatory peptides may be evaluated through chromatographic analysis, mass spectrometric testing, binding assays, cell-free systems, or appropriately designed in vitro models. The methodology selected depends on the research objective and the laboratory’s established protocols.
Results may vary according to peptide form, purity, concentration, storage history, assay design, environmental conditions, control selection, and the characteristics of the experimental model. References to vascular, endothelial, or tissue-specific research describe areas of laboratory investigation only and do not establish a physiological benefit, safety profile, or approved medical application.
Important Research Notice: Nordsci provides lot-specific analytical documentation for its research materials. The applicable Certificate of Analysis should be reviewed for reported identity, purity, testing methods, and other batch-specific findings.
THIS PRODUCT IS INTENDED EXCLUSIVELY FOR LABORATORY RESEARCH USE. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR CLINICAL, DIAGNOSTIC, THERAPEUTIC, PREVENTIVE, FOOD, COSMETIC, VETERINARY, OR HOUSEHOLD USE.
Laboratories may use Vesugen as a defined peptide material in analytical workflows examining identity, purity, chromatographic behavior, molecular characteristics, or stability under controlled conditions.
Vesugen may be incorporated into non-clinical experiments examining the properties of short peptide sequences. Appropriate reference materials, controls, replicates, and validated analytical methods should be selected according to the research objective.
Qualified researchers may evaluate Vesugen within appropriately designed in vitro systems. These experiments may focus on assay validation, model sensitivity, peptide interactions, or measurable responses under predetermined laboratory conditions.
Vesugen may be compared with reference materials or other peptide sequences in controlled research examining analytical differences, sequence-dependent behavior, stability, or experimental reproducibility.
Vesugen (20mg) should be handled only by qualified personnel in an appropriately equipped laboratory. Researchers should use suitable personal protective equipment, contamination controls, calibrated instruments, validated methods, and complete documentation practices.
Protocol Design Considerations: Experimental findings may be affected by purity, peptide form, storage history, temperature, light exposure, moisture, assay conditions, control selection, and model variability. These factors should be documented and controlled to support reproducible laboratory workflows.
No information provided on this page should be interpreted as preparation, dosing, administration, application, safety, or clinical guidance.
This material is supplied exclusively for controlled laboratory research. Researchers are responsible for conducting appropriate risk assessments and complying with applicable institutional, local, state, and federal requirements.
Lot-specific analytical documentation is available for Vesugen (20mg). The Certificate of Analysis provides the reported findings for the tested batch and may include identity, purity, and applicable analytical-method information.
COA results apply only to the identified lot and should not be generalized to other batches. Laboratories should verify that the lot number on the vial corresponds with the documentation maintained in their research records.
Nordsci Peptides supplies Vesugen (20mg) as a research-grade laboratory material in lyophilized form. Batch-specific documentation is available to assist laboratories with material identification, recordkeeping, and research traceability.
Product selection should be based on the laboratory’s analytical requirements, approved research protocol, institutional policies, and applicable regulations.
IMPORTANT: Vesugen (20mg) is supplied exclusively for laboratory research use. It is not a drug, dietary supplement, food, cosmetic, or veterinary product. It is not approved for human or animal consumption or for clinical, diagnostic, therapeutic, or preventive use. No dosing, administration, or application guidance is provided.
